Pharmaceutical News

RSS

Gift of $1.5 million will fund DMT research at UC San Diego

One of the most powerful psychedelics known, N,N-dimethyltryptamine (DMT) has been described as causing imaginative visuals akin to the dream state.

11 Jul 2023

Prescription stimulants safe for treating ADHD, study finds

Many parents whose kids take prescription stimulants like Ritalin to treat ADHD worry that it could lead to illicit drug use later.

11 Jul 2023

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

11 Jul 2023

The American Journal of Health Economics articles examine policies to address opioid crisis

The August 2023 issue of the American Journal of Health Economics will feature a cluster of articles that examine the opioid crisis.

10 Jul 2023

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of antifungals available on the market.

10 Jul 2023

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

10 Jul 2023

What you need to know about the drug price fight in those TV ads

In recent months ominous ads about prescription drugs have flooded the TV airwaves. Perhaps by design, it's not always clear who's sponsoring the ads or why.

10 Jul 2023

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Eli Lilly and Company announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation (MA) for mirikizumab (OMVOH®) for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

10 Jul 2023

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

Unique plant extract mixture has potent anti-acne effects

Researchers evaluate the efficacy of FRO, a formula composed of fermented Rhus verniciflua Stokes and Orostachys japonicus, against acne pathogenesis via antimicrobial assessment and an in vitro analysis. FRO was found to contain phenolics such as gallic acid, fisetin, quercetin, and kaempferol and was determined to alleviate acne by inhibiting the growth of Cutibacterium acnes, inflammation, and excess sebum.

9 Jul 2023

COVID-19 strikes harder on low-income communities in LA; Vaccination proves key to reducing disparity

COVID-19 incidence rates were higher in lower-income communities compared to higher-income communities before vaccines became available in Los Angeles. However, after vaccination, the disparity in COVID-19 incidence diminished, with the lowest-income communities experiencing the highest impact of vaccination.

5 Jul 2023

Moderna COVID-19 vaccine effective in children five and under

mRNA-1273 vaccine (Moderna) shows strong effectiveness in reducing symptomatic SARS-CoV-2 infection and COVID-19-related hospitalization in children aged 6 months to 5 years. Further research is needed to explore long-term effectiveness and the potential need for booster doses.

5 Jul 2023

Less than half of approved new drugs add substantial therapeutic value over existing treatments

New drugs are often used not only for one disease (first approved indication) but also for other diseases (supplemental indications).

5 Jul 2023

Medical cannabis laws have no effect on opioid prescriptions, study finds

State laws allowing medical cannabis use did not reduce prescriptions for opioids or other therapies for chronic, non-cancer pain, according to a policy analysis by Weill Cornell Medicine investigators.

5 Jul 2023

Patients squeezed in fight over who gets to bill for pricey infusion drugs

Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country.

5 Jul 2023

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

Anti-amyloid immunotherapies for Alzheimer's disease require thorough evaluation of their efficacy, safety, and cost-effectiveness. Key questions regarding statistical analyses, treatment effects, and disease course modification guide evidence-based consideration of these drugs.

4 Jul 2023

A novel RSV vaccine that could be effective across all ages

Researchers evaluate the in vivo efficacy of a respiratory syncytial virus vaccine in old and young rats.

4 Jul 2023

New oral films could revolutionize drug delivery for patients

Conventional ways of administering medication - by swallowing tablets, consuming bitter syrups, injections or rectal insertions - could be distressing and unpleasant for some patients, especially young children or the elderly.

3 Jul 2023

CRISPR/Cas9-based screening identifies potential therapies for non-alcoholic fatty liver disease

Activation of the NRF2 transcription factor shows promise as a potential treatment approach for non-alcoholic fatty liver disease (NAFLD), a condition associated with oxidative stress and liver damage. By screening FDA-approved drugs, researchers identified six compounds that enhanced NRF2 activity and demonstrated protective effects against oxidative stress and lipid accumulation.

3 Jul 2023

Breaking the myth: opioids provide no advantage for acute back pain, study finds

The first placebo-controlled trial of opioids in acute low back and neck pain.

3 Jul 2023

Previous
1
...
46
47
48
49
50
51
52
...
1433
Next

Pharmaceutical News

Gift of $1.5 million will fund DMT research at UC San Diego

Prescription stimulants safe for treating ADHD, study finds

Novel vaccine against Lyme disease reported to be safe and effective

The American Journal of Health Economics articles examine policies to address opioid crisis

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

What you need to know about the drug price fight in those TV ads

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Unique plant extract mixture has potent anti-acne effects

COVID-19 strikes harder on low-income communities in LA; Vaccination proves key to reducing disparity

Moderna COVID-19 vaccine effective in children five and under

Less than half of approved new drugs add substantial therapeutic value over existing treatments

Medical cannabis laws have no effect on opioid prescriptions, study finds

Patients squeezed in fight over who gets to bill for pricey infusion drugs

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

A novel RSV vaccine that could be effective across all ages

New oral films could revolutionize drug delivery for patients

CRISPR/Cas9-based screening identifies potential therapies for non-alcoholic fatty liver disease

Breaking the myth: opioids provide no advantage for acute back pain, study finds

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News